AC Immune (ACIU) Interest Coverage Ratio Growth (5y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.67% |
| Dec 31, 2025 | -19.53% |
| Sep 30, 2025 | -2.98% |
| Jun 30, 2025 | 6.72% |
| Mar 31, 2025 | -27.78% |
| Dec 31, 2024 | -22.68% |
| Sep 30, 2024 | -1.05% |
| Jun 30, 2024 | 83.90% |
| Mar 31, 2024 | 50.88% |
| Dec 31, 2023 | 28.38% |
| Sep 30, 2023 | 8.66% |
| Jun 30, 2023 | 3.72% |
| Mar 31, 2023 | 17.17% |
| Dec 31, 2022 | -556.77% |
| Sep 30, 2022 | 142.16% |
| Jun 30, 2022 | 91.86% |
| Mar 31, 2022 | 91.13% |
| Dec 31, 2021 | 18.99% |
| Sep 30, 2021 | 71.24% |
| Mar 31, 2021 | 34.94% |
| Dec 31, 2020 | 27.23% |
| Sep 30, 2020 | 25.56% |